Tumour necrosis factor-α blockers in the treatment of psoriasis

被引：0
|
作者：
Lebwohl, M. [1 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2010年 / 162卷 / 06期
关键词：
psoriasis; tumour necrosis factor-alpha; SQUAMOUS-CELL CARCINOMA; RHEUMATOID-ARTHRITIS; CONSENSUS CONFERENCE; RISK; METHOTREXATE; THERAPY; LYMPHOMA; INFLIXIMAB; MALIGNANCIES; METAANALYSIS;
D O I：
10.1111/j.1365-2133.2010.09835.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1169 / 1171
页数：3
相关论文
共 50 条
  • [1] Blockers of tumour necrosis factor-α: mechanisms of action
    Eder, Piotr
    Lykowska-Szuber, Liliana
    Stawczyk-Eder, Kamila
    Krela-Kazmierczak, Iwona
    Linke, Krzysztof
    PRZEGLAD GASTROENTEROLOGICZNY, 2011, 6 (05): : 290 - 298
  • [2] Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis
    Ryan, C.
    Kelleher, J.
    Fagan, M. F.
    Rogers, S.
    Collins, P.
    Barker, J. N. W. N.
    Allen, M.
    Hagan, R.
    Renfro, L.
    Kirby, B.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (04) : 519 - 524
  • [3] Ustekinumab in the treatment of psoriasis in patients resistant to tumour necrosis factor-α inhibitors
    O'Shea, S. J.
    Rogers, S.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (02) : 444 - 444
  • [4] Are there effects of tumour necrosis factor-α blockers on male fertility?
    Colsman, A.
    Kiesewetter, F.
    Heppt, F.
    Sticherling, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E158 - E158
  • [5] Overexpression of tumour necrosis factor-α-converting enzyme in psoriasis
    Kawaguchi, M
    Mitsuhashi, Y
    Kondo, S
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (05) : 915 - 919
  • [6] Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers
    Goiriz, R.
    Dauden, E.
    Perez-Gala, S.
    Guhl, G.
    Garcia-Diez, A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) : 176 - 179
  • [7] Tumour Necrosis Factor-α Blockers in Rheumatoid ArthritisReview of the Clinical Experience
    Corinne Richard-Miceli
    Maxime Dougados
    BioDrugs, 2001, 15 : 251 - 259
  • [8] Hidradenitis suppurativa:: are tumour necrosis factor-α blockers the ultimate alternative?
    Brunasso, A. M. G.
    Delfino, C.
    Massone, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (03) : 761 - 763
  • [9] Drug survival rates for tumour necrosis factor-α antagonists in psoriasis
    Burden, A. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (05) : 940 - 941
  • [10] Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-α blockers: perioperative interruption of tumour necrosis factor-α blockers decreases complications?
    Kawakami, Kosei
    Ikari, Katsunori
    Kawamura, Koichiro
    Tsukahara, So
    Iwamoto, Takuji
    Yano, Koichiro
    Sakuma, Yu
    Tokita, Asami
    Momohara, Shigeki
    RHEUMATOLOGY, 2010, 49 (02) : 341 - 347
12345